全自动生化免疫流水线及试剂
Search documents
中标企业频频弃标,大型医疗设备采购有何难言之隐?
Mei Ri Jing Ji Xin Wen· 2025-12-15 12:07
Core Viewpoint - The article discusses the increasing trend of companies voluntarily abandoning bids for medical equipment procurement projects in China, highlighting the complexities and challenges within the industry, including price competition and regulatory issues [2][12]. Group 1: Bid Abandonment Cases - In 2025, there has been a noticeable increase in cases of companies voluntarily abandoning bids in the medical equipment sector, with notable examples including GE Healthcare abandoning a bid just three days after winning [2][9]. - The case of WanDong Medical, which won a bid for a 1.5T MRI system at a price of 4 million yuan, is particularly striking as the company later chose to abandon the bid after a lengthy and complicated procurement process [4][12]. - The article notes that this year marks the fifth case of a medical equipment manufacturer abandoning a bid, indicating a troubling trend in the industry [9][12]. Group 2: Reasons for Bid Abandonment - Common reasons for voluntary bid abandonment include underestimating production capacity before bidding and discovering that the actual profit margins do not meet expectations after winning the bid [13][14]. - The practice of aggressive price competition, where companies submit low bids to win contracts, often leads to situations where the awarded price is unsustainable for project operation, prompting companies to abandon the bid [13][14]. - High-priced bids may also be abandoned if hospitals express concerns about the pricing, potentially leading to discussions that result in the company voluntarily withdrawing [13][14]. Group 3: Industry Dynamics and Challenges - The medical equipment procurement landscape has shifted towards centralized purchasing, which has significantly reduced costs but has also intensified price competition among manufacturers [20][21]. - The article highlights that the current environment is characterized by high inventory levels and a price war among manufacturers, which has led to declining revenues and profits for leading medical device companies [20][21]. - Regulatory bodies are taking action to address issues of price competition, with recent announcements aimed at maintaining fair market practices and preventing below-cost bidding [21].